Description: Analysis of Alzheimer’s Disease as a potential Critical Illness insurance benefit trigger.

Description: Life insurers offer Juvenile riders or low face amount whole life plans. The market is seeking multimillion dollar juvenile policies. What are the risks?

Description: Article discussing a research project to determine the risk selection efficacy of e-underwriting in conjunction with the use of e-data such as MIB, MVR and prescription med history.

Description: Paper discussing issues pertaining to setting and managing issue limits and reinsurance retention limits for life insurance.

Description: These were discussion papers on the paper, 'The Korean War Hazard' by James T. Phillips.

Description: In the wake of the pandemic, much of the insurance industry is now endeavoring to find sustainable, longer-term solutions among many forced innovations – and to ensure that temporary adaptations add value beyond mere change.

Description: This is a discussion from the June 2000 meeting of the Society of Actuaries in San Diego, looking at the evolution of e-commerce for the insurance business.

Description: This session 36TS of the Toronto Spring Meeting discusses selected concepts that relate to risk appraisal in new business issuance and underwriting. Specific attention is focused on the relative values of underwriting tools, namely fluid collection: blood, urine, and oral fluid. From the Record of the Society of Actuaries, Volume 27, No. 2, Session 36TS

Description: 2004 SOA Spring Meeting, Anaheim, CA. In this session panelists presented an overview of underwriting processes for a variety of product lines. They also discuss related topics such as identifying keys to underwriting decisions, the cost of underwriting and protective value, and ensuring consistency with pricing assumptions. Some of the underwriting tools discussed were use of RX history, credit checks, DMV history, and fraud data bases.

Description: Presented at May 2005 Spring Meeting. Panelists discuss the insuring of the aging population in respect to assessment of the health of the insured and resulting mortality costs.